Skip to content

Calcium and Vitamin D Malnutrition in Elderly Women

Calcium and Vitamin D Malnutrition in Elderly Women

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00352170
Enrollment
1180
Registered
2006-07-14
Start date
2000-05-31
Completion date
2005-07-31
Last updated
2008-08-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoporosis, Secondary Hyperparathyroidism

Keywords

calcium, vitamin D, secondary hyperparathyroidism, osteoporotic fractures

Brief summary

This study is designed to test whether calcium supplementation alone or calcium plus vitamin D reduces the incidence of fractures, reduces high parathyroid secretory activity, and halts bone loss in a population-based sample of women 55+ years of age. * A calcium supplement of 1400 mg/d will significantly reduce the cumulative incidence of spine and appendicular fractures over four years for independently living, rural women 55 years of age and older compared to similar women on their usual diets. * A calcium supplement of 1400 mg/d plus 1100 IU vitamin D/d will significantly reduce the cumulative incidence of spine and appendicular fractures compared to a calcium supplement only.

Detailed description

We are conducting a 4-year randomized, double-blind, placebo controlled trial of calcium or calcium with vitamin D supplementation. We randomly sampled the population of healthy, independent living women 55+ years in nine rural counties. We randomly assigned 1180 women to one of three groups: Group 1 receives calcium (1400 mg/d) and vitamin D placebo, Group 2 receives both calcium (1400 mg/d) and vitamin D (1100 IU/d) and Group 3 receives both placebos. A full-service market research firm randomly selected telephone numbers from all households with listed numbers in the nine-county rural sample area. The firm continued calling until 1180 women were selected who met the inclusion and exclusion criteria and were willing to participate in a four year prospective study of calcium and vitamin D supplementation. The participants were enrolled into study between May 2000 and July 2001. Participants have study visits every six months. Annually the following are performed: bone density scans, height and weight, brief medical history including medicine changes, fracture surveillance, and compliance with calcium and vitamin D. At baseline and end of study, spine x-rays and dietary recall were obtained.

Interventions

DIETARY_SUPPLEMENTcalcium supplementation

calcium carbonate 1500 mg/day

DIETARY_SUPPLEMENTcalcium and vitamin D3 supplementation

calcium carbonate 1500 mg/day vitamin D3 1000 IU/day

DIETARY_SUPPLEMENTPlacebo

calcium and vitamin D3 placebo

Sponsors

GlaxoSmithKline
CollaboratorINDUSTRY
Creighton University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
55 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

healthy women ages 55 and older who were at least four years postmenopausal living independently in a nine-county rural area of Nebraska \-

Exclusion criteria

1\) chronic kidney disease, 2) Paget's metabolic bone disease, and 3) history of cancer except for superficial basal or squamous cell carcinoma of the skin and \-

Design outcomes

Primary

MeasureTime frame
fractures4 years

Secondary

MeasureTime frame
changes in bone mass and density4 years
changes in serum dihydroxyvitamin Done year and four years
changes in serum parathyroid hormoneone year and four years
cancerfour years
Fallsfour years

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 7, 2026